These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 28117883)

  • 41. Clinical significance of epithelial-mesenchymal transition and cancer stem cells.
    Topcul M; Cetin I
    J BUON; 2016; 21(2):312-9. PubMed ID: 27273939
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Targeting the facilitative glucose transporter GLUT1 inhibits the self-renewal and tumor-initiating capacity of cancer stem cells.
    Shibuya K; Okada M; Suzuki S; Seino M; Seino S; Takeda H; Kitanaka C
    Oncotarget; 2015 Jan; 6(2):651-61. PubMed ID: 25528771
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Isolation, identification, and characterization of cancer stem cells: A review.
    Abbaszadegan MR; Bagheri V; Razavi MS; Momtazi AA; Sahebkar A; Gholamin M
    J Cell Physiol; 2017 Aug; 232(8):2008-2018. PubMed ID: 28019667
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Implication of cancer stem cells in cancer drug development and drug delivery.
    Chow EK
    J Lab Autom; 2013 Feb; 18(1):6-11. PubMed ID: 22893634
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A role for cancer stem cells in therapy resistance: cellular and molecular mechanisms.
    Cojoc M; Mäbert K; Muders MH; Dubrovska A
    Semin Cancer Biol; 2015 Apr; 31():16-27. PubMed ID: 24956577
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Trastuzumab (herceptin) targets gastric cancer stem cells characterized by CD90 phenotype.
    Jiang J; Zhang Y; Chuai S; Wang Z; Zheng D; Xu F; Zhang Y; Li C; Liang Y; Chen Z
    Oncogene; 2012 Feb; 31(6):671-82. PubMed ID: 21743497
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Approaches for targeting cancer stem cells drug resistance.
    Rosa R; D'Amato V; De Placido S; Bianco R
    Expert Opin Drug Discov; 2016 Dec; 11(12):1201-1212. PubMed ID: 27700193
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Napabucasin: An Update on the First-in-Class Cancer Stemness Inhibitor.
    Hubbard JM; Grothey A
    Drugs; 2017 Jul; 77(10):1091-1103. PubMed ID: 28573435
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The self-renewal signaling pathways utilized by gastric cancer stem cells.
    Fu Y; Li H; Hao X
    Tumour Biol; 2017 Apr; 39(4):1010428317697577. PubMed ID: 28378630
    [TBL] [Abstract][Full Text] [Related]  

  • 50. EMT, CTCs and CSCs in tumor relapse and drug-resistance.
    Mitra A; Mishra L; Li S
    Oncotarget; 2015 May; 6(13):10697-711. PubMed ID: 25986923
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Liver cancer stem cell markers: Progression and therapeutic implications.
    Sun JH; Luo Q; Liu LL; Song GB
    World J Gastroenterol; 2016 Apr; 22(13):3547-57. PubMed ID: 27053846
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Molecular targeted therapy for the treatment of gastric cancer.
    Xu W; Yang Z; Lu N
    J Exp Clin Cancer Res; 2016 Jan; 35():1. PubMed ID: 26728266
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cancer stem cells as the relevant biomass for drug discovery.
    Winquist RJ; Furey BF; Boucher DM
    Curr Opin Pharmacol; 2010 Aug; 10(4):385-90. PubMed ID: 20630801
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Mitochondrial biology in cancer stem cells.
    Loureiro R; Mesquita KA; Magalhães-Novais S; Oliveira PJ; Vega-Naredo I
    Semin Cancer Biol; 2017 Dec; 47():18-28. PubMed ID: 28673608
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Recent advances and future trends in the targeted therapy of metastatic gastric cancer.
    Al-Batran SE; Werner D
    Expert Rev Gastroenterol Hepatol; 2014 Jul; 8(5):555-69. PubMed ID: 24665840
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cancer stem cells: the 'heartbeat' of gastric cancer.
    Xu G; Shen J; Ou Yang X; Sasahara M; Su X
    J Gastroenterol; 2013 Jul; 48(7):781-97. PubMed ID: 23184096
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Nano-delivery system targeting to cancer stem cell cluster of differentiation biomarkers.
    Mokhtarzadeh A; Hassanpour S; Vahid ZF; Hejazi M; Hashemi M; Ranjbari J; Tabarzad M; Noorolyai S; de la Guardia M
    J Control Release; 2017 Nov; 266():166-186. PubMed ID: 28941992
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Companion diagnostics for the targeted therapy of gastric cancer.
    Yoo C; Park YS
    World J Gastroenterol; 2015 Oct; 21(39):10948-55. PubMed ID: 26494953
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Concise review: Emerging concepts in clinical targeting of cancer stem cells.
    Rasheed ZA; Kowalski J; Smith BD; Matsui W
    Stem Cells; 2011 Jun; 29(6):883-7. PubMed ID: 21509907
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Gastric cancer stem cells: a novel therapeutic target.
    Singh SR
    Cancer Lett; 2013 Sep; 338(1):110-9. PubMed ID: 23583679
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.